Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users
Patients treated with SGLT2i had a small but significantly higher risk of postoperative eKA but lower risks of postoperative AKI and 30-day mortality.
Authors
- Anusha Badathala
- Catherine L. Chen
- Arthur W. Wallace
- Bocheng Jing (ORCID: https://orcid.org/0000-0002-2021-5055)
- Matthieu Legrand (ORCID: https://orcid.org/0000-0001-9788-5316)
- Kaiwei Lu
- Roberta T. Tallarico (ORCID: https://orcid.org/0000-0002-0033-9560)
- Shweta Chawla (ORCID: https://orcid.org/0000-0003-3333-5475)
- Yanting Luo (ORCID: https://orcid.org/0000-0003-0439-6164)
Institutions
- San Francisco VA Medical Center (US)
- University of California, San Francisco (US)
- Washington University in St. Louis (US)
- Northern California Institute for Research and Education (US)
Publication Details
- Journal
- JAMA Surgery
- Published
- 2025-04-30
- DOI
- https://doi.org/10.1001/jamasurg.2025.0940
- Citations
- 22
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 28.49
Funders
- National Institutes of Health
- University of California, San Francisco
- National Institute of General Medical Sciences